Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Marshall Islands Healthcare Brief.
Press releases published on October 15, 2025
Allsup Shares Five Ways To Get More Value From Medicare During Open Enrollment
Belleville, Illinois, Oct. 15, 2025 (GLOBE NEWSWIRE) -- As the Medicare Open Enrollment Period begins, an Allsup expert outlines practical steps to reduce out-of-pocket costs, keep trusted doctors and medications, and make use of plan extras. Tricia …
Eascra Biotech Named to Fast Company’s “Next Big Things in Tech 2025”
BOSTON, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Fast Company has named Eascra Biotech, a nanomedicine startup, to its annual Next Big Things in Tech list for 2025. Fast Company is recognizing Eascra’s groundbreaking work using microgravity to manufacture …
Ketabon Presents New Data Showing Antidepressant Effects of Oral Ketamine (KET01) Are Independent of Dissociation
MUNICH, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Ketabon GmbH (“Ketabon” or “the Company”), a joint venture between HMNC Brain Health and Develco Pharma, today announced new data from a post hoc analysis of the KET01-02 Phase 2 clinical trial evaluating KET01, …
WeightWatchers for Business Annual Report Shows Breakthrough Weight Loss Results and Health Outcomes
Members See 46% Improvement in Work-Related Quality of Life and 53% Improvement in Overall Quality of Life WeightWatchers Members Lost 21% of Their Body Weight, Outperforming Results by Other Telehealth Providers NEW YORK, Oct. 15, 2025 (GLOBE NEWSWIRE) …
Calgary Health Foundation donors come through for those with kidney disease
Calgary, Alberta, Canada, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Calgary Health Foundation is pleased to announce the opening of a new complex and multidisciplinary kidney care clinic in Calgary. The previous Glomerulonephritis Clinic at the Sheldon M. Chumir …
National Ground Water Association Launches Water Well Map Expanding Access to Water Well Data Nationwide
Westerville, OH, Oct. 15, 2025 (GLOBE NEWSWIRE) -- The National Ground Water Association (NGWA) and WellOwner.org announce the launch of a new online tool that will greatly expand access to water well data nationwide. NGWA Water Well Map is an easy-to-use …
Canada’s Largest Family Medicine Gathering Comes to Winnipeg This November
Event Information: Family Medicine Forum November 5–8, 2025 (Winnipeg) fmf.cfpc.ca MISSISSAUGA, Ontario, Oct. 15, 2025 (GLOBE NEWSWIRE) -- From November 5–8, 2025, family doctors will gather in the heart of Canada to celebrate, learn, and network at the …
Le plus grand rassemblement de médecins de famille au pays posera ses valises à Winnipeg en novembre
Information sur l’événement : Forum en médecine familiale Du 5 au 8 novembre 2025 (Winnipeg) fmf.cfpc.ca/fr/ MISSISSAUGA, Ontario, 15 oct. 2025 (GLOBE NEWSWIRE) -- Du 5 au 8 novembre 2025, les médecins de famille se retrouveront en plein centre du Canada …
Spherix Global Insights Expands Hematology Franchise to Include Oncology, Enhancing Advisory Services and Delivering Deeper Physician and Market Insights
EXTON, PA, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Spherix Global Insights, a leading independent market intelligence and advisory firm that delivers commercial value to the global life sciences industry, today announced the expansion of its hematology franchise …
Empowering Patients: Annual Breast Reconstruction Awareness Day Returns Oct. 15
Arlington Heights, Ill, Oct. 15, 2025 (GLOBE NEWSWIRE) -- The American Society of Plastic Surgeons (ASPS) in partnership with The Plastic Surgery Foundation (The PSF) is ensuring patients have access to informed choices during the 14th annual Breast …
Evaluation of SON-1010 Using a Patient-Derived Tumoroid Platform to Support an Ongoing Phase 1 Study in Patients with Sarcoma
HOUSTON, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) is collaborating with Spanios on a non-clinical study using New Alternate Methodologies (NAM)-based patient-derived tumoroid (PDT) platforms that emulate the …
Baylor Genetics Presents New Data on Clinical and Diagnostic Utility of RNA Sequencing for Rare Disease at the American Society of Human Genetics 2025 Annual Meeting
HOUSTON, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Baylor Genetics, a clinical diagnostic laboratory at the forefront of genetic testing, today showcased new research in RNA sequencing (RNA-seq) to uncover critical information leading to rare disease diagnoses at …
Noom Introduces “Mindful Art Break” — A Weekly Practice Designed to Spark Awe, Relieve Stress, and Boost Psychological Wellbeing
Noom open sources wellbeing by releasing its art-impact research, AI art-scoring tools, and the A.R.T. (Art Research Tool) into the public domain PRINCETON, N.J., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Noom, the leading platform for preventive health, today …
BioRestorative Therapies to Participate in the 2025 Maxim Growth Summit
MELVILLE, N.Y., Oct. 15, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a regenerative medicine innovator focused on stem cell-based therapies and products, is pleased to announce its …
Biomerica Reports First Quarter Fiscal 2026 Financial Results
Reported Improved Gross Margin from Contribution from Higher-Margin Product Mix Operating Expenses Continued to Decline Compared to the First Quarter of the Prior Fiscal Year, Reflecting the Company’s Ongoing Focus on Cost Reduction and Operational …
Quercis Pharma and Thomas Lines Nominated for Prestigious Prix Galien USA “Best Startup” Award
ZUG, Switzerland, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Quercis Pharma AG, a clinical-stage biopharmaceutical company developing inflammasome-modulating therapies in oncology, thrombosis, and inflammatory diseases, today announced that it, along with Founder …
Anteris Receives First European Regulatory Clearance to Commence DurAVR® THV Global Pivotal Trial (the “PARADIGM Trial”)
MINNEAPOLIS and BRISBANE, Australia, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (Anteris or the Company) (NASDAQ: AVR, ASX: AVR) a global structural heart company committed to designing, developing, and commercializing cutting-edge …
Artelo Biosciences Announces Expanded Clinical Data to be Presented on both ART26.12 and ART27.13 at the 8th Annual Cannabinoid & Endocannabinoid Drug Development Summit
ART26.12 Phase 1 Data Demonstrated No Safety Concerns, Predictable Linear Plasma Exposure, and Options for Dosing in Either Fed or Fasted Conditions ART27.13 Interim Phase 2 Data Showed Substantial Weight Gain and Activity Improvements in the Treated …